Interleukin-1-receptor antagonist in type 2 diabetes mellitus - Reply
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Interleukin-1-receptor antagonist in type 2 diabetes mellitus - Reply. / Mandrup-Poulsen, Thomas Rolf; Seifert, B.; Donath, M.Y.
In: New England Journal of Medicine, Vol. 357, No. 3, 2007, p. 303-303.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Mandrup-Poulsen, TR, Seifert, B & Donath, MY 2007, 'Interleukin-1-receptor antagonist in type 2 diabetes mellitus - Reply', New England Journal of Medicine, vol. 357, no. 3, pp. 303-303.
APA
Mandrup-Poulsen, T. R., Seifert, B., & Donath, M. Y. (2007). Interleukin-1-receptor antagonist in type 2 diabetes mellitus - Reply. New England Journal of Medicine, 357(3), 303-303.
Vancouver
Mandrup-Poulsen TR, Seifert B, Donath MY. Interleukin-1-receptor antagonist in type 2 diabetes mellitus - Reply. New England Journal of Medicine. 2007;357(3):303-303.
Author
Bibtex
@article{3c9dfb2020ec11ddbc23000ea68e967b,
title = "Interleukin-1-receptor antagonist in type 2 diabetes mellitus - Reply",
abstract = "Udgivelsesdato: 2007/7/19",
author = "Mandrup-Poulsen, {Thomas Rolf} and B. Seifert and M.Y. Donath",
year = "2007",
language = "English",
volume = "357",
pages = "303--303",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachusetts Medical Society",
number = "3",
}
RIS
TY - JOUR
T1 - Interleukin-1-receptor antagonist in type 2 diabetes mellitus - Reply
AU - Mandrup-Poulsen, Thomas Rolf
AU - Seifert, B.
AU - Donath, M.Y.
PY - 2007
Y1 - 2007
N2 - Udgivelsesdato: 2007/7/19
AB - Udgivelsesdato: 2007/7/19
M3 - Journal article
VL - 357
SP - 303
EP - 303
JO - New England Journal of Medicine
JF - New England Journal of Medicine
SN - 0028-4793
IS - 3
ER -
ID: 4039286